February 14, 2013Open Access

Prevalence of potential drug–drug interactions in cancer patients treated with oral anticancer drugs

Key Points

Key points are not available for this paper at this time.

Abstract

Potential drug-drug interactions are very common among cancer patients on oral cancer therapy. Physicians and pharmacists should be more aware of these potential interactions.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Cite this study

Leeuwen et al. (Thu,) studied this question.

www.synapsesocial.com/papers/69d81dfb52654bb436d1827b — DOI: https://doi.org/10.1038/bjc.2013.48

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

NCCN Task Force Report: Bone Health in Cancer Care· 2013 · 412 citations
Corticosteroid Use and Peptic Ulcer Disease: Role of Nonsteroidal Anti-inflammatory Drugs· 1991 · 607 citations
Effects of St. John's Wort on Irinotecan Metabolism· 2002 · 447 citations
Drugs and Falls in Older People: A Systematic Review and Meta‐analysis: I. Psychotropic Drugs· 1999 · 1,151 citations
Overview of the changing paradigm in cancer treatment: Oral chemotherapy

Authors

Roelof W. F. van Leeuwen

Daniel H.S. Brundel

Cees Neef

Journals

British Journal of Cancer

Actions

Institutions

Radboud University Nijmegen

University of Groningen

Erasmus MC

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Prevalence of potential drug–drug interactions in cancer patients treated with oral anticancer drugs

Key Points

Abstract

Citation Network

Connected Papers

Discussion

Cite this study

Also consider

Authors

Journals

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion